abstract |
The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibody modulates IL6 signaling for the treatment or prevention of IL6 related diseases or disorders, particularly inflammatory disorders, rheumatoid arthritis (RA), angiogenesis, and cancer. |